Skip to content
10-Q

Quarterly Report

INHIBRX, INC.

0001739614-23-000043

← back to feed
Filed
May 8, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2023 · Apr 30, 2023 43.62M sh
Cash And Equivalents Q1 2023 · Mar 31, 2023 $234.25M
Cash And Equivalents Q1 2023 · Dec 31, 2022 $273.87M
Current Liabilities Q1 2023 · Mar 31, 2023 $32.64M
Current Liabilities Q1 2023 · Dec 31, 2022 $27.58M
Total Liabilities Q1 2023 · Mar 31, 2023 $238.58M
Total Liabilities Q1 2023 · Dec 31, 2022 $232.82M
Current Assets Q1 2023 · Mar 31, 2023 $243.78M
Current Assets Q1 2023 · Dec 31, 2022 $280.49M
Total Assets Q1 2023 · Mar 31, 2023 $253.72M
Total Assets Q1 2023 · Dec 31, 2022 $290.88M
Shares Diluted Q1 2023 · Mar 31, 2022 39.02M sh
Capex Q1 2023 · Mar 31, 2022 $117K
Operating Cash Flow Q1 2023 · Mar 31, 2022 −$26.94M
Stockholders Equity Q1 2023 · Mar 31, 2022 $27.35M
Stockholders Equity Q1 2023 · Dec 31, 2021 $52.38M
Eps Diluted Q1 2023 · Mar 31, 2022 −$0.80
Eps Basic Q1 2023 · Mar 31, 2022 −$0.80
Sga Expense Q1 2023 · Mar 31, 2022 $5.05M
Rd Expense Q1 2023 · Mar 31, 2022 $24.9M
Net Income Q1 2023 · Mar 31, 2022 −$31.25M
Operating Income Q1 2023 · Mar 31, 2022 −$29.02M
Revenue Q1 2023 · Mar 31, 2022 $929K